Aycan Zehra, Berberoglu Merih, Adiyaman Pelin, Ergür Ayça Törel, Ensari Arzu, Evliyaoglu Olcay, Siklar Zeynep, Ocal Gönül
Department of Pediatric Endocrinology, Ankara University School of Medicine, Ankara, Turkey.
J Pediatr Endocrinol Metab. 2004 Nov;17(11):1565-9. doi: 10.1515/jpem.2004.17.11.1565.
Latent autoimmune diabetes mellitus in adults (LADA) is characterized by clinical presentation as type 2 diabetes mellitus after 25 years of age, initial control achieved with oral hypoglycemic agents for at least 6 months, presence of autoantibodies and some immunogenetic features of type 1 diabetes mellitus. An 8.3 year-old girl was referred to our pediatric endocrinology department because of incidental glucosuria. She did not complain of polyuria, polydipsia, or weight loss. Her body mass index (BMI) was at the 80th percentile. Fasting glucose was 126 mg/dl, and OGTT glucose level at 120 min was 307 mg/dl. Although C-peptide levels were normal, her first phase insulin response (FIR) was lower than the 1st percentile. Anti-insulin antibody (AIA), islet cell antibody (ICA), and anti-glutamic acid decarboxylase (antiGAD) were negative. According to the clinical and laboratory findings, she was diagnosed as having type 2 diabetes mellitus. She was started with oral anti-diabetic treatment for a period of 1 year. Insulin had to be initiated for worsening of HbA1c levels. In the fourth year of follow-up, she was admitted to our hospital with diabetic ketoacidosis although she was on an intensive insulin regimen. At this time, C-peptide levels were low, antiGAD and AIA were positive with HLA DR3/DQ2 haplotype. In addition, her thyroid peroxidase antibody and endomysium antibody were found to be high at follow-up. Small intestinal biopsy revealed celiac disease. This patient may represent the first case of latent autoimmune diabetes mellitus in children (LADC) with autoimmune thyroiditis and celiac disease.
成人隐匿性自身免疫性糖尿病(LADA)的特征为25岁之后出现2型糖尿病的临床表现,最初至少6个月通过口服降糖药实现血糖控制,存在自身抗体以及1型糖尿病的一些免疫遗传特征。一名8.3岁女孩因偶然发现糖尿被转诊至我院儿科内分泌科。她没有多尿、烦渴或体重减轻的主诉。她的体重指数(BMI)处于第80百分位。空腹血糖为126mg/dl,口服葡萄糖耐量试验(OGTT)120分钟时的血糖水平为307mg/dl。尽管C肽水平正常,但她的第一相胰岛素反应(FIR)低于第1百分位。抗胰岛素抗体(AIA)、胰岛细胞抗体(ICA)和抗谷氨酸脱羧酶(抗GAD)均为阴性。根据临床和实验室检查结果,她被诊断为2型糖尿病。她开始接受口服抗糖尿病治疗1年。由于糖化血红蛋白(HbA1c)水平恶化,不得不开始使用胰岛素。在随访的第四年,尽管她采用强化胰岛素治疗方案,但仍因糖尿病酮症酸中毒入住我院。此时,C肽水平较低,抗GAD和AIA呈阳性,伴有HLA DR3/DQ2单倍型。此外,随访时发现她的甲状腺过氧化物酶抗体和肌内膜抗体升高。小肠活检显示患有乳糜泻。该患者可能代表首例患有自身免疫性甲状腺炎和乳糜泻的儿童隐匿性自身免疫性糖尿病(LADC)。